Insider Transactions in Q4 2020 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2020
|
Kenneth Hallock Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.25%
|
$5,000
$5.39 P/Share
|
|
Nov 23
2020
|
Frank Joseph Daugherty Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.14%
|
$5,000
$5.1 P/Share
|
|
Nov 20
2020
|
Eric Rothe Director |
BUY
Open market or private purchase
|
Direct |
2,000
+0.63%
|
$10,000
$5.4 P/Share
|
|
Nov 20
2020
|
Kenneth Hallock Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.25%
|
$5,000
$5.37 P/Share
|
|
Nov 20
2020
|
David Mc Williams Director |
BUY
Open market or private purchase
|
Direct |
1,500
+0.24%
|
$7,500
$5.4 P/Share
|
|
Nov 19
2020
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.17%
|
$10,000
$5.4 P/Share
|
|
Nov 10
2020
|
Pankaj Amrit Patel > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
561,798
-100.0%
|
-
|